Mark Davies
Chairman chez NEUROTECH INTERNATIONAL LIMITED
Profil
Mark Davies is the founder of Cygnet Capital Pty Ltd.
(Investment Management), which was founded in 2003.
He held the title of General Manager at the firm.
Mr. Davies is also the founder of 1861 Capital Pty Ltd.
Mr. Davies's current job(s) include being the Non-Executive Chairman at Neurotech International Ltd.
since 2019 and the Chairman at Tryptamine Therapeutics Ltd.
Mr. Davies's former job includes being the Non-Executive Chairman at Exopharm Ltd.
Mr. Davies's education history includes completing his undergraduate degree at The University of Western Australia.
Postes actifs de Mark Davies
| Sociétés | Poste | Début |
|---|---|---|
| NEUROTECH INTERNATIONAL LIMITED | Chairman | 16/08/2022 |
1861 Capital Pty Ltd.
 1861 Capital Pty Ltd. Financial ConglomeratesFinance 1861 Capital Pty Ltd. provides investment services. The private company is based in Dalkeith, Australia. The Australian company was founded by Mark Davies. Mark Davies has been the CEO since incorporation. | Founder | - |
Anciens postes connus de Mark Davies
| Sociétés | Poste | Fin |
|---|---|---|
Cygnet Capital Pty Ltd. (Investment Management)
 Cygnet Capital Pty Ltd. (Investment Management) Investment ManagersFinance Cygnet Capital Pty Ltd. (Investment Management) (Cygnet Capital-IM) is the investment management division of Cygnet Capital Pty Ltd., a brokerage firm headquartered in Melbourne, Australia. The firm was co-founded by Darien Jagger and Jonathan Rosham in 2003. Cygnet Capital-IM identifies and structures investment opportunities in emerging companies. | Founder | - |
| EXOPHARM | Chairman | - |
Cygnet Capital Pty Ltd.
 Cygnet Capital Pty Ltd. Investment Banks/BrokersFinance Cygnet Capital Pty Ltd. is an investment firm that has been identifying and structuring investment opportunities in emerging companies for over twenty years. The private company is based in Melbourne, Australia. The Australian company engages founders with focus, talent, and hunger. and has subsidiaries in Australia. The company was founded in 2003 by Darien Jagger, Jonathan Rosham, Mark Davies. Jonathan Rosham has been the CEO since 2003. | Founder | - |
Formation de Mark Davies
| The University of Western Australia | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NEUROTECH INTERNATIONAL LIMITED | Health Technology |
| Entreprise privées | 4 |
|---|---|
Cygnet Capital Pty Ltd.
Cygnet Capital Pty Ltd. Investment Banks/BrokersFinance Cygnet Capital Pty Ltd. is an investment firm that has been identifying and structuring investment opportunities in emerging companies for over twenty years. The private company is based in Melbourne, Australia. The Australian company engages founders with focus, talent, and hunger. and has subsidiaries in Australia. The company was founded in 2003 by Darien Jagger, Jonathan Rosham, Mark Davies. Jonathan Rosham has been the CEO since 2003. | Finance |
Cygnet Capital Pty Ltd. (Investment Management)
Cygnet Capital Pty Ltd. (Investment Management) Investment ManagersFinance Cygnet Capital Pty Ltd. (Investment Management) (Cygnet Capital-IM) is the investment management division of Cygnet Capital Pty Ltd., a brokerage firm headquartered in Melbourne, Australia. The firm was co-founded by Darien Jagger and Jonathan Rosham in 2003. Cygnet Capital-IM identifies and structures investment opportunities in emerging companies. | Finance |
1861 Capital Pty Ltd.
1861 Capital Pty Ltd. Financial ConglomeratesFinance 1861 Capital Pty Ltd. provides investment services. The private company is based in Dalkeith, Australia. The Australian company was founded by Mark Davies. Mark Davies has been the CEO since incorporation. | Finance |
Exopharm Ltd.
 Exopharm Ltd. Pharmaceuticals: MajorHealth Technology Exopharm Ltd. engages in the research and development of biopharmaceutical drugs. The company was founded by Ian Dixon and Gregor Lichtfuss in 2013 and is headquartered in Camberwell, Australia. | Health Technology |
